Clinical Trials in Illinois

Showing 6521-6540 of 19,692 trials

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

NCT04382586

The primary objective of this study was to evaluate if the addition of zanubrutinib to supportive care increases the respiratory failure-free survival rate at Day 28 in participants hospitalized for Corona Virus Disease 2019 (COVID-19) and pulmonary distress not receiving mechanical ventilation.

COVID-19 Pulmonary ComplicationsCOVID-19

BeiGene63 participantsStarted Jul 2020

Fullerton, California, United States • Washington D.C., District of Columbia, United States • Thomasville, Georgia, United States +7 more locations

COMPLETED121 miles

Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

NCT02039557

This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.

Patients Transplanted With NiCord/CordIn (Omidubicel)

Gamida Cell ltd33 participantsStarted May 2014

Oakland, California, United States • Maywood, Illinois, United States • Durham, North Carolina, United States +7 more locations

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

Find Trials by Condition in Illinois

An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies

First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Trial Comparing Peripheral I.V. Catheter Complication Rates of Two Different Catheter Dressings

Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function.

ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy

Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma

A Study of LY3022855 In Participants With Breast or Prostate Cancer

A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms